Winfried Wingender
Impact in
- Biotechnology top 1%
- Enzyme Production and Characterization
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Analytical Methods in Pharmaceuticals 6
-
- Enzyme Production and Characterization 5
- Co-authors
- Ernst Truscheit (3 shared papers)Delf D. Schmidt (3 shared papers)Bodo Junge (3 shared papers)Werner Frommer (3 shared papers)Lutz Peter Müller (2 shared papers)Wolf Bernd Frommer (1 shared paper)D Förster (2 shared papers)P. Schacht (2 shared papers)
- Journals
- European Journal of Clinical Pharmacology (3 papers)The Journal of Antibiotics (1 paper)Die Naturwissenschaften (1 paper)The Journal of Clinical Pharmacology (1 paper)Atherosclerosis (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Winfried Wingender
26 papers receiving 1.3k citations
Winfried Wingender's Hit Papers
Peers
Comparison fields: 5 of 96
- Biotechnology 398
- Pharmacology 333
- Organic Chemistry 508
- Endocrinology, Diabetes and Metabolism 259
- Molecular Medicine 48
Countries citing papers authored by Winfried Wingender
This map shows the geographic impact of Winfried Wingender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winfried Wingender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winfried Wingender more than expected).
Fields of papers citing papers by Winfried Wingender
This network shows the impact of papers produced by Winfried Wingender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winfried Wingender. The network helps show where Winfried Wingender may publish in the future.
Co-authors
The 25 scholars most cited alongside Winfried Wingender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors Hit paper breakdown → | 1981 | 446 |
| 2 | ?-Glucosidase inhibitors Hit paper breakdown → | 1977 | 436 |
| 3 | 1984 | 140 | |
| 4 | 1981 | 133 | |
| 5 | 1970 | 78 | |
| 6 | Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin. | 1997 | 50 |
| 7 | 1987 | 30 | |
| 8 | 1988 | 26 | |
| 9 | 1988 | 24 | |
| 10 | Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1. | 1985 | 15 |
| 11 | 1974 | 14 | |
| 12 | 1992 | 11 | |
| 13 | 1975 | 7 | |
| 14 | 1992 | 6 | |
| 15 | 1998 | 6 | |
| 16 | 1987 | 5 | |
| 17 | 1997 | 4 | |
| 18 | 1987 | 3 | |
| 19 | 1988 | 3 | |
| 20 | 1988 | 3 |
About Winfried Wingender
Winfried Wingender is a scholar working on Analytical Chemistry, Biotechnology, Biochemistry, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (6 papers), Enzyme Production and Characterization (5 papers), Cardiac electrophysiology and arrhythmias (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Epilepsy research and treatment (3 papers), Diet and metabolism studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Microbial Metabolites in Food Biotechnology (2 papers). The work is most often cited by research in Biotechnology (398 citations), Pharmacology (333 citations), Organic Chemistry (508 citations), Endocrinology, Diabetes and Metabolism (259 citations) and Molecular Medicine (48 citations). Winfried Wingender has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Ernst Truscheit, Delf D. Schmidt, Bodo Junge, Werner Frommer, Lutz Peter Müller, Wolf Bernd Frommer, D Förster, P. Schacht, Dieter Beermann and Klaus H. Hofmann. Their work appears in journals such as European Journal of Clinical Pharmacology, The Journal of Antibiotics, Die Naturwissenschaften, The Journal of Clinical Pharmacology and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.